Daniela Papadia

Daniela Papadia

Company: Oblique Therapeutics

Job title: Head of Discovery & Preclinical R&D - Ion Channel Targets in Pain

Seminars:

Stimuli-Selective Antibodies Against hTRPV1 – Targeting Pain 9:30 am

Sharing insights from the AbiProt antibody platform to develop functional antibodies targeting ion channels Maximizing pain relief through inhibition of TRPV1 channel with mAbs Circumventing side effects associated with previous small molecule antagonistsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.